Search Results 271-280 of 19015 for creatine

1. Phase I Cabazitaxel, Mitoxantrone, and Prednisone Metastatic Castration-Resistant Prostate Cancer - Mayo Clinic

   Creatinine < 1.5 x upper limits of normal (ULN). If Cr. > 1.5 x ULN, then calculated creatinine clearance > 40cc/min. ALT and AST within normal limits ...

2. Testing the Addition of an Anti-cancer Drug, ASTX727, to Chemotherapy (Paclitaxel) and Immunotherapy (Pembrolizumab) for Metastatic Triple-Negative Breast Cancer - Mayo Clinic

   Participants can be on stable dose of erythropoietin (>= approximately 3 months). - Creatinine clearance (CrCl) >= 30 mL/min (within 14 days of registration) - ...

3. A Study of the Effect of Vedolizumab in Conjunction with Structured Semi-Vegetarian Diet on the Treatment of Ulcerative Colitis - Mayo Clinic

   ... creatinine >2 × ULN; Antibiotic use within past 14 days; Probiotics use within past 7 days. Participating Mayo Clinic locations. Study statuses change often ...

4. Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment (enrollment by invitation only) - Mayo Clinic

   Creatinine clearance < 50 mL/min; Note: Other protocol defined Inclusion/Exclusion criteria may apply. Participating Mayo Clinic locations. Study statuses ...

5. Oxaliplatin, Leucovorin Calcium, and Fluorouracil with or without Celecoxib in Treating Patients with Stage III Colon Cancer Previously Treated with Surgery - Mayo Clinic

   Required initial laboratory values. Granulocytes ≥ 1,500/μL; Platelet count ≥ 100,000/μL; Creatinine ≤ 1.5 times upper limit of normal (ULN); Total Bilirubin ...

6. Ibrutinib in Treating Patients With Relapsed Hairy Cell Leukemia - Mayo Clinic

   Creatinine ≤ 2.0 mg/dL, and/or. Creatinine clearance (estimated GFR [Cockcroft-Gault]) ≥30 mL/min. Total bilirubin ≤ 1.5 x ULN (unless disease related or ...

7. Phase 1b Safety Study of CMB305 in Patients With Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1 - Mayo Clinic

   Renal: Creatinine > 1.5x ULN; Other: INR (prothrombin time ratio) or partial thromboplastin time (PTT) >1.5 x ULN. History of other cancer within 3 years ...

8. High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma - Mayo Clinic

   Creatinine no greater than 1.8 mg/dL. Cardiovascular: No history of active ischemic heart disease; No cerebrovascular disease; No congestive heart failure (New ...

9. Isotretinoin With or Without Monoclonal Antibody Ch14.18, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma - Mayo Clinic

   Creatinine clearance or radioisotope glomerular filtration rate (GFR) ≥ 70 mL/min/1.73 m^2 or a serum creatinine based on age/gender as follows: No greater ...

10. Evaluation Of Rate Adaptive Pacing On Chronotropic Response In Preserved Ejection Fraction HF - Mayo Clinic

    Renal impairment with serum creatinine > 3 mg/dL; Anemia with hemoglobin < 8 g/dL or major bleeding event within the past 60 days. Primary diagnosis of ...